Galena Biopharma 2016 Outlook Focuses On 'High Value' Cancer Immunotherapy Pipeline

By: via Benzinga
Shares of Galena Biopharma Inc (NASDAQ: GALE) were trading lower by more than 5 percent at $0.770 on Wednesday after the company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.